Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza

Background. Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown. Methods. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group evalu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kimberlin, David W., Acosta, Edward P., Prichard, Mark N., Sánchez, Pablo J., Ampofo, Krow, Lang, David, Ashouri, Negar, Vanchiere, John A., Abzug, Mark J., Abughali, Nazha, Caserta, Mary T., Englund, Janet A., Sood, Sunil K., Spigarelli, Michael G., Bradley, John S., Lew, Judy, Michaels, Marian G., Wan, Wen, Cloud, Gretchen, Jester, Penelope, Lakeman, Fred D., Whitley, Richard J., Giles, Dusty, Cotton, Bari, Judy, Sharon, Cowie, Margaret, Francis, Jeanne, Evans, Candice, O'Donnell, Nan, Shiraishi, Ofelia Vargas, Latiolais, Lisa, Aymami, Valeri, Dole, Ken, Gaultier, Julie, Lofthus, Gerry, Kinnunen, Diane, Lacombe, Kirsten, Stellato, Nancy, Denlinger, Julie, Hingtgen, Sara, Mason, Christina, Jeffrey, Noreen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2013
Schlagworte:
Major Articles and Brief Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563309/
https://ncbi.nlm.nih.gov/pubmed/23230059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis765
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge